Intracardiac Echocardiography Market / ICE Market Size, Share & Trends by Product (Ultrasound, Catheter, Console, Software), Application, End user & Region Global Forecasts to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS
• 1.4 MARKET SCOPE
  • 1.4.1 MARKETS COVERED
• 1.5 YEARS CONSIDERED
• 1.6 CURRENCY CONSIDERED
• 1.7 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key industry insights
    • 2.2.2.3 Breakdown of primaries
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
    • 2.3.1.2 Approach 2: Customer-based market estimation
    • 2.3.1.3 Approach 3: Top-down approach
    • 2.3.1.4 Approach 4: Primary interviews
• 2.4 DATA TRIANGULATION & MARKET BREAKDOWN
• 2.5 MARKET SHARE ASSESSMENT
• 2.6 STUDY ASSUMPTIONS
• 2.7 ASSUMPTIONS
• 2.8 RISK ASSESSMENT
• 2.9 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET OVERVIEW
• 4.2 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
• 4.3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION AND END USER, 2023 (USD MILLION)
• 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Emergence of predictive analytics in ICE technology
    • 5.2.1.2 Expanding clinical use cases of ICE technology
    • 5.2.1.3 Ongoing integration of ICE technology with other imaging modalities
    • 5.2.1.4 Rising prevalence of cardiac disorders
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Premium product pricing
    • 5.2.2.2 Dearth of healthcare professionals
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Broadening clinical applications of ICE in structural heart disease interventions
    • 5.2.3.2 Advances in 3D and real-time 3D (4D) imaging
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Technical limitations
    • 5.2.4.2 Increased pricing pressure on market players
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4.2 KEY REGULATORY GUIDELINES
    • 5.4.2.1 North America
      • 5.4.2.1.1 US
      • 5.4.2.1.2 Canada
    • 5.4.2.2 Europe
    • 5.4.2.3 Asia Pacific
      • 5.4.2.3.1 Japan
      • 5.4.2.3.2 India
      • 5.4.2.3.3 China
• 5.5 REIMBURSEMENT SCENARIO
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT & FUNDING SCENARIO
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Phased-array ICE
    • 5.8.1.2 Rotational ICE
    • 5.8.1.3 Doppler imaging
    • 5.8.1.4 3D ICE technology
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Intravascular ultrasound (IVUS)
    • 5.8.2.2 Value-added software (AI and IoT)
    • 5.8.2.3 Clinical decision support systems
    • 5.8.2.4 Electrophysiology (EP) mapping systems
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Event monitors
    • 5.8.3.2 Holter monitors
• 5.9 VALUE CHAIN ANALYSIS
  • 5.9.1 RESEARCH & DEVELOPMENT
  • 5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
  • 5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
• 5.10 SUPPLY CHAIN ANALYSIS
  • 5.10.1 PROMINENT COMPANIES
  • 5.10.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.10.3 END USERS
• 5.11 PRICING ANALYSIS
• 5.12 PATENT ANALYSIS
• 5.13 TRADE ANALYSIS
• 5.14 KEY CONFERENCES & EVENTS, 2024-2025
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 ADJACENT MARKET ANALYSIS
• 5.18 UNMET NEEDS & KEY PAIN POINTS
• 5.19 ARTIFICIAL INTELLIGENCE IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE)

6 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE
  • 6.2.1 2D ULTRASOUND SYSTEMS
    • 6.2.1.1 Increasing integration of modern ICE systems with other diagnostic systems to drive market growth
  • 6.2.2 3D/4D ULTRASOUND SYSTEMS
    • 6.2.2.1 Increasing incidence of cardiovascular diseases worldwide to drive growth
  • 6.2.3 DOPPLER ULTRASOUND SYSTEMS
    • 6.2.3.1 Higher resolution imaging and advanced Doppler techniques to enhance capability of ICE systems
• 6.3 ICE CATHETERS
  • 6.3.1 DOPPLER ICE CATHETERS
    • 6.3.1.1 Growing preference for minimally invasive cardiac procedures to support market growth
  • 6.3.2 PHASED-ARRAY ICE CATHETERS
    • 6.3.2.1 High cost and limited applications to restrict market growth
  • 6.3.3 FIXED-ARRAY ICE CATHETERS
    • 6.3.3.1 High demand for advanced cardiac imaging solutions to drive innovation and adoption of fixed-array catheters
  • 6.3.4 MECHANICAL ROTATIONAL ICE CATHETERS
    • 6.3.4.1 Innovations in catheter technology to boost market growth
• 6.4 ICE CONSOLES
  • 6.4.1 CART/TROLLEY-BASED CONSOLES
    • 6.4.1.1 Rising geriatric population to fuel market growth
  • 6.4.2 HANDHELD/PORTABLE CONSOLES
    • 6.4.2.1 Increasing adoption of portable consoles in healthcare facilities to drive market growth
• 6.5 GUIDING CATHETERS & SHEATHS
  • 6.5.1 INCREASING INTEGRATION OF GUIDING CATHETERS & SHEATHS WITH PORTABLE ICE CONSOLES TO PROPEL MARKET GROWTH
• 6.6 DISPOSABLE ACCESSORIES
  • 6.6.1 COST OF DISPOSABLE ACCESSORIES TO PLAY SIGNIFICANT ROLE IN DRIVING MARKET GROWTH
• 6.7 SOFTWARE
  • 6.7.1 INCREASING ADOPTION OF PREDICTIVE ANALYTICS FOR REAL-TIME IMAGING TO BOOST MARKET

7 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 STRUCTURAL HEART DEFECTS
  • 7.2.1 MITRAL VALVE REPAIR/REPLACEMENT
    • 7.2.1.1 Growing burden of cardiovascular diseases to drive market
  • 7.2.2 AORTIC VALVE REPLACEMENT
    • 7.2.2.1 Growing demand for effective imaging tools like ICE to boost market
  • 7.2.3 OTHER STRUCTURAL HEART DEFECTS
• 7.3 ELECTROPHYSIOLOGY
  • 7.3.1 GROWING INTEGRATION OF ICE WITH MAPPING SYSTEMS TO DRIVE MARKET GROWTH
• 7.4 LEFT ATRIAL APPENDAGE CLOSURE
  • 7.4.1 BENEFITS SUCH AS MINIMIZATION OF RADIATION EXPOSURE IN PROCEDURES LIKE LAA CLOSURE TO SUPPORT GROWTH
• 7.5 CARDIAC MONITORING
  • 7.5.1 BETTER CLINICAL DECISION-MAKING AND IMPROVED PATIENT OUTCOMES TO SUPPORT SEGMENT GROWTH
• 7.6 OTHER APPLICATIONS

8 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & SURGICAL CENTERS
  • 8.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF ICE TECHNOLOGIES TO BOOST MARKET
• 8.3 AMBULATORY SURGICAL CENTERS
  • 8.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE GROWTH
• 8.4 HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS
  • 8.4.1 GROWING USE OF ICE IN CATH LABS FOR MINIMALLY INVASIVE CARDIAC PROCEDURES TO BOOST MARKET
• 8.5 INDEPENDENT DIAGNOSTIC CENTERS
  • 8.5.1 SPECIALIZED EXPERTISE AND ADVANCED ICE TECHNOLOGY IN INDEPENDENT DIAGNOSTIC CENTERS TO BOOST GROWTH
• 8.6 OTHER END USERS

9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 US
    • 9.2.1.1 Growing number of FDA approvals for ICE devices to support market growth
  • 9.2.2 CANADA
    • 9.2.2.1 Growing public-private funding for research to drive market growth
• 9.3 EUROPE
  • 9.3.1 GERMANY
    • 9.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
  • 9.3.2 UK
    • 9.3.2.1 Increasing public & private investments to contribute to market growth
  • 9.3.3 FRANCE
    • 9.3.3.1 Statutory health insurance system to support market growth
  • 9.3.4 ITALY
    • 9.3.4.1 Rising incidence of cardiac diseases to drive adoption of ICE devices
  • 9.3.5 SPAIN
    • 9.3.5.1 Growing number of surgical procedures to drive market growth in Spain
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 JAPAN
    • 9.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
  • 9.4.2 CHINA
    • 9.4.2.1 Growing focus of local and international market players to favor market growth
  • 9.4.3 INDIA
    • 9.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
  • 9.4.4 AUSTRALIA
    • 9.4.4.1 R&D tax incentive program to support market growth
  • 9.4.5 SOUTH KOREA
    • 9.4.5.1 Supportive government initiatives to drive market growth
  • 9.4.6 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 BRAZIL
    • 9.5.1.1 Brazil to dominate LATAM market
  • 9.5.2 MEXICO
    • 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
  • 9.5.3 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GCC COUNTRIES
    • 9.6.1.1 Developments in healthcare infrastructure and high government expenditure to drive market
  • 9.6.2 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
• 10.3 REVENUE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS
  • 10.4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE, BY KEY PLAYER, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Product footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 COMPANY VALUATION AND FINANCIAL METRICS
• 10.8 PRODUCT/BRAND COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 10.9.2 DEALS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 MEDTRONIC
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 ABBOTT
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches and approvals
      • 11.1.2.3.2 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 SIEMENS HEALTHINEERS AG
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches and approvals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 GE HEALTHCARE
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product approvals
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 BOSTON SCIENTIFIC CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 PHILIPS HEALTHCARE
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches and approvals
      • 11.1.6.3.2 Deals
      • 11.1.6.3.3 Expansions
    • 11.1.6.4 MnM view
      • 11.1.6.4.1 Key strengths
      • 11.1.6.4.2 Strategic choices
      • 11.1.6.4.3 Weaknesses and competitive threats
  • 11.1.7 JOHNSON & JOHNSON MEDTECH
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches and approvals
      • 11.1.7.3.2 Deals
    • 11.1.7.4 MnM view
      • 11.1.7.4.1 Key strengths
      • 11.1.7.4.2 Strategic choices
      • 11.1.7.4.3 Weaknesses and competitive threats
  • 11.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches
      • 11.1.8.3.2 Deals
  • 11.1.9 EDWARDS LIFESCIENCES CORPORATION
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 CANON MEDICAL SYSTEMS CORPORATION
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product launches
      • 11.1.10.3.2 Deals
  • 11.1.11 FUJIFILM HOLDINGS CORPORATION
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Deals
  • 11.1.12 GUERBET
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
  • 11.1.13 TERUMO CORPORATION
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
  • 11.1.14 LIVANOVA
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 INFRAREDX INC.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
  • 11.1.16 STEREOTAXIS, INC.
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Deals
  • 11.1.17 B. BRAUN SE
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
  • 11.1.18 ESAOTE SPA
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Product launches
• 11.2 OTHER PLAYERS
  • 11.2.1 CHISON MEDICAL TECHNOLOGIES CO., LTD.
  • 11.2.2 SHIFAMED, LLC
  • 11.2.3 CONAVI MEDICAL INC.
  • 11.2.4 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.
  • 11.2.5 BK MEDICAL
  • 11.2.6 BENQ MEDICAL TECHNOLOGY
  • 11.2.7 ECHONOUS INC.
  • 11.2.8 VOLTA MEDICAL
  • 11.2.9 TRIVITRON HEALTHCARE
  • 11.2.10 ECHOPIXEL
  • 11.2.11 CATHVISION
  • 11.2.12 PIE MEDICAL IMAGING BV

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

List of Tables

• TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
• TABLE 2 STUDIES ON AI IN ECHOCARDIOGRAPHIC DIAGNOSTICS
• TABLE 3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 9 US: CLASSIFICATION OF MEDICAL EQUIPMENT
• TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
• TABLE 11 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
• TABLE 12 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
• TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
• TABLE 14 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
• TABLE 15 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2023
• TABLE 16 IMPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 17 EXPORT DATA FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES (HS CODE 901819), BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 18 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024-2025
• TABLE 19 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES
• TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
• TABLE 21 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS
• TABLE 22 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 23 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 24 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 25 2D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 26 3D/4D ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 27 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 28 ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 29 ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 30 DOPPLER ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 31 PHASED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 32 FIXED-ARRAY ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 33 MECHANICAL ROTATIONAL ICE CATHETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 34 ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 35 ICE CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 36 CART/TROLLEY-BASED CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 37 HANDHELD/PORTABLE CONSOLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 38 GUIDING CATHETERS & SHEATHS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 39 ICE DISPOSABLE ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 ICE SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 41 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 42 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 43 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 44 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR MITRAL VALVE REPAIR/REPLACEMENT, BY REGION, 2022-2029 (USD MILLION)
• TABLE 45 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR AORTIC VALVE REPLACEMENT, BY REGION, 2022-2029 (USD MILLION)
• TABLE 46 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER STRUCTURAL HEART DEFECTS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 47 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR ELECTROPHYSIOLOGY, BY REGION, 2022-2029 (USD MILLION)
• TABLE 48 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR LEFT ATRIAL APPENDAGE CLOSURE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 49 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR CARDIAC MONITORING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 50 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 51 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 52 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 53 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 54 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 55 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 56 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 57 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 59 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 60 NORTH AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 61 NORTH AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 62 NORTH AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 63 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 64 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 65 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 66 US: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 67 US: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 68 US: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 69 US: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 70 CANADA: RESEARCH GRANTS IN INTRACARDIAC ECHOCARDIOGRAPHY
• TABLE 71 CANADA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 72 CANADA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 73 CANADA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 74 CANADA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 75 EUROPE: PRODUCT APPROVALS IN INTRACARDIAC ECHOCARDIOGRAPHY
• TABLE 76 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 77 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 78 EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 79 EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 80 EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 81 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 82 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 83 EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 84 GERMANY: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 85 GERMANY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 86 GERMANY: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 87 GERMANY: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 88 UK: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 89 UK: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 90 UK: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 91 UK: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 92 FRANCE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 93 FRANCE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 94 FRANCE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 95 FRANCE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 96 ITALY: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 97 ITALY: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 98 ITALY: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 99 ITALY: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 100 SPAIN: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 101 SPAIN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 102 SPAIN: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 103 SPAIN: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 104 REST OF EUROPE: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 105 REST OF EUROPE: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 106 REST OF EUROPE: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 107 REST OF EUROPE: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 108 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 109 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 110 ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 111 ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 112 ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 113 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 114 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 115 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 116 JAPAN: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY
• TABLE 117 JAPAN: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 118 JAPAN: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 119 JAPAN: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 120 JAPAN: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 121 CHINA: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY
• TABLE 122 CHINA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 123 CHINA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 124 CHINA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 125 CHINA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 126 INDIA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 127 INDIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 128 INDIA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 129 INDIA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 130 AUSTRALIA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 131 AUSTRALIA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 132 AUSTRALIA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 133 AUSTRALIA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 134 SOUTH KOREA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 135 SOUTH KOREA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 136 SOUTH KOREA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 137 SOUTH KOREA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 138 REST OF ASIA PACIFIC: RECENT DEVELOPMENTS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
• TABLE 139 REST OF ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 140 REST OF ASIA PACIFIC: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 141 REST OF ASIA PACIFIC: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 142 REST OF ASIA PACIFIC: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 143 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 144 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 145 LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 146 LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 147 LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 148 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 149 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 150 LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 151 BRAZIL: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 152 BRAZIL: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 153 BRAZIL: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 154 BRAZIL: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 155 MEXICO: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 156 MEXICO: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 157 MEXICO: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 158 MEXICO: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 159 REST OF LATIN AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 160 REST OF LATIN AMERICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 161 REST OF LATIN AMERICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 162 REST OF LATIN AMERICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 163 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 164 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 165 MIDDLE EAST & AFRICA: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 166 MIDDLE EAST & AFRICA: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 167 MIDDLE EAST & AFRICA: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 168 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 169 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET FOR STRUCTURAL HEART DEFECTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 170 MIDDLE EAST & AFRICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 171 GCC COUNTRIES: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 172 GCC COUNTRIES: ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 173 GCC COUNTRIES: ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 174 GCC COUNTRIES: ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 175 REST OF MIDDLE EAST & AFRICA (ROMEA): INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 176 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 177 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CATHETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 178 REST OF MIDDLE EAST & AFRICA (ROMEA): ICE CONSOLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 179 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
• TABLE 180 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DEGREE OF COMPETITION
• TABLE 181 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PRODUCT FOOTPRINT
• TABLE 182 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: APPLICATION FOOTPRINT
• TABLE 183 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: END-USER FOOTPRINT
• TABLE 184 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: REGION FOOTPRINT
• TABLE 185 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
• TABLE 186 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• TABLE 187 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
• TABLE 188 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DEALS, JANUARY 2021-JUNE 2024
• TABLE 189 MEDTRONIC: COMPANY OVERVIEW
• TABLE 190 MEDTRONIC: PRODUCTS OFFERED
• TABLE 191 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 192 MEDTRONIC: DEALS, JANUARY 2020-JUNE 2024
• TABLE 193 ABBOTT: COMPANY OVERVIEW
• TABLE 194 ABBOTT: PRODUCTS OFFERED
• TABLE 195 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 196 ABBOTT: DEALS, JANUARY 2020-JUNE 2024
• TABLE 197 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
• TABLE 198 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
• TABLE 199 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 200 GE HEALTHCARE: COMPANY OVERVIEW
• TABLE 201 GE HEALTHCARE: PRODUCTS OFFERED
• TABLE 202 GE HEALTHCARE: PRODUCT APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 203 GE HEALTHCARE: DEALS, JANUARY 2020-JUNE 2024
• TABLE 204 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
• TABLE 205 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
• TABLE 206 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2020- JUNE 2024
• TABLE 207 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020-JUNE 2024
• TABLE 208 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2020-JUNE 2024
• TABLE 209 PHILIPS HEALTHCARE: COMPANY OVERVIEW
• TABLE 210 PHILIPS HEALTHCARE: PRODUCTS OFFERED
• TABLE 211 PHILIPS HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 212 PHILIPS HEALTHCARE: DEALS, JANUARY 2020-JUNE 2024
• TABLE 213 PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2020-JUNE 2024
• TABLE 214 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW
• TABLE 215 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED
• TABLE 216 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2020-JUNE 2024
• TABLE 217 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2020-JUNE 2024
• TABLE 218 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
• TABLE 219 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
• TABLE 220 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 221 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2020-JUNE 2024
• TABLE 222 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
• TABLE 223 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
• TABLE 224 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
• TABLE 225 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
• TABLE 226 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 227 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2020-JUNE 2024
• TABLE 228 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
• TABLE 229 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
• TABLE 230 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 231 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020-JUNE 2024
• TABLE 232 GUERBET: COMPANY OVERVIEW
• TABLE 233 GUERBET: PRODUCTS OFFERED
• TABLE 234 GUERBET: DEALS, JANUARY 2020-JUNE 2024
• TABLE 235 TERUMO CORPORATION: COMPANY OVERVIEW
• TABLE 236 TERUMO CORPORATION: PRODUCTS OFFERED
• TABLE 237 TERUMO CORPORATION: DEALS, JANUARY 2020-JUNE 2024
• TABLE 238 LIVANOVA: COMPANY OVERVIEW
• TABLE 239 LIVANOVA: PRODUCTS OFFERED
• TABLE 240 INFRAREDX INC.: COMPANY OVERVIEW
• TABLE 241 INFRAREDX INC.: PRODUCTS OFFERED
• TABLE 242 STEREOTAXIS, INC.: COMPANY OVERVIEW
• TABLE 243 STEREOTAXIS, INC.: PRODUCTS OFFERED
• TABLE 244 STEREOTAXIS, INC.: DEALS, JANUARY 2020-JUNE 2024
• TABLE 245 B. BRAUN SE: COMPANY OVERVIEW
• TABLE 246 B. BRAUN SE: PRODUCTS OFFERED
• TABLE 247 ESAOTE SPA: COMPANY OVERVIEW
• TABLE 248 ESAOTE SPA: PRODUCTS OFFERED
• TABLE 249 ESAOTE SPA: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2024
• TABLE 250 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
• TABLE 251 SHIFAMED, LLC: COMPANY OVERVIEW
• TABLE 252 CONAVI MEDICAL INC.: COMPANY OVERVIEW
• TABLE 253 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.: COMPANY OVERVIEW
• TABLE 254 BK MEDICAL: COMPANY OVERVIEW
• TABLE 255 BENQ MEDICAL TECHNOLOGY: COMPANY OVERVIEW
• TABLE 256 ECHONOUS INC.: COMPANY OVERVIEW
• TABLE 257 VOLTA MEDICAL: COMPANY OVERVIEW
• TABLE 258 TRIVITRON HEALTHCARE: COMPANY OVERVIEW
• TABLE 259 ECHOPIXEL: COMPANY OVERVIEW
• TABLE 260 CATHVISION: COMPANY OVERVIEW
• TABLE 261 PIE MEDICAL IMAGING BV: COMPANY OVERVIEW

List of Figures

• FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
• FIGURE 5 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
• FIGURE 6 TOP-DOWN APPROACH
• FIGURE 7 DATA TRIANGULATION METHODOLOGY
• FIGURE 8 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS
• FIGURE 9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 10 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 GEOGRAPHICAL SNAPSHOT OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
• FIGURE 13 INCREASING DEMAND FOR PREDICTIVE ANALYTICS IN ICE DEVICES-MAJOR FACTOR DRIVING INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
• FIGURE 14 ASIA PACIFIC REGIONAL MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 15 HOSPITALS & SURGICAL CENTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 17 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 18 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: PORTER'S FIVE FORCES MODEL
• FIGURE 19 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: ECOSYSTEM ANALYSIS
• FIGURE 20 NUMBER OF DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, 2018-2022 (USD MILLION)
• FIGURE 21 NUMBER OF INVESTOR DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY KEY PLAYER, 2018-2022
• FIGURE 22 VALUE OF INVESTOR DEALS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
• FIGURE 23 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: VALUE CHAIN ANALYSIS
• FIGURE 24 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 25 AVERAGE SELLING PRICE OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY PRODUCT (USD THOUSAND)
• FIGURE 26 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY KEY PLAYER, 2021-2023 (USD)
• FIGURE 27 AVERAGE SELLING PRICE TREND OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, BY REGION, 2021-2023 (USD)
• FIGURE 28 PATENT DETAILS FOR INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES, JANUARY 2013-DECEMBER 2023
• FIGURE 29 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
• FIGURE 30 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: BUYING CRITERIA
• FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INTRACARDIAC ECHOCARDIOGRAPHY (ICE) DEVICES
• FIGURE 32 NORTH AMERICA: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SNAPSHOT
• FIGURE 33 ASIA PACIFIC: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SNAPSHOT
• FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET (2019-2023)
• FIGURE 35 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE ANALYSIS (2023)
• FIGURE 36 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS)
• FIGURE 37 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY FOOTPRINT
• FIGURE 38 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 39 EV/EBITDA OF KEY VENDORS
• FIGURE 40 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 41 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2023)
• FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2023)
• FIGURE 44 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
• FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
• FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 47 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023)
• FIGURE 48 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023)
• FIGURE 49 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
• FIGURE 50 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 51 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 52 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 53 GUERBET: COMPANY SNAPSHOT (2023)
• FIGURE 54 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 55 LIVANOVA: COMPANY SNAPSHOT (2022)
• FIGURE 56 STEREOTAXIS, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 57 B. BRAUN SE: COMPANY SNAPSHOT (2023)